Estimation of cardiovascular risk in patients with diabetes mellitus type 2
Abstract
Introduction: Diabetic people have between two and three times more risk of cardiovascular morbidity and mortality than those who do not suffer from the disease.
Objective: To estimate cardiovascular risk in patients with type 2 diabetes mellitus treated in a Health Area.
Methods: A descriptive and cross-sectional study was carried out on 103 patients with type 2 diabetes mellitus, belonging to the Family Medical Office No. 23 of the Carlos J. Finlay polyclinic, Songo-La Maya municipality, Santiago de Cuba province, from January to December 2023. Qualitative variables and quantitative (age, year of diagnosis and duration of the disease) were studied; Cardiovascular risk was estimated according to the model for predicting cardiovascular risk in people with type 2 diabetes.
Results: A predominance of the female sex was observed (58.3%). Most patients had arterial hypertension (76.0%) and microalbuminuria (31.2%). The average age of the patients was 65.5 years and on average they had a duration of diabetes of 8.6 years. The cardiovascular risk evaluation placed 43.3% of the population at a moderate level and 25.7% at high risk.
Conclusions: The diabetic patients studied showed a moderate to high risk of presenting cardiovascular events. It is necessary to carry out educational interventions in these patients and their families to achieve favorable changes in lifestyles and improve disease control, thus preventing complications and the occurrence of fatal events in the coming years.
DeCS: DIABETES MELLITUS, TYPE 2/complications; HEART DISEASE RISK FACTORS; PRIMARY HEALTH CARE; RISK FACTORS; HEALTH STATUS INDICATORS.
Downloads
References
1. Organización Mundial de la Salud [Internet].Suiza: OMS; 2023 [actualizado 05 Abr 2023; citado 23 Nov 2023].Diabetes. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/diabetes
2. OPS/OMS [Internet]. Washington: OPS; 2023 [actualizado 19 Nov 2023; citado 20 Nov 2023].Diabetes. Disponible en: https://www.paho.org/es/temas/diabetes
3. International Diabetes Federation [Internet]. Bruselas: FID; 2023 [actualizado 22 Nov 2023; citado 23 Nov 2023]. Datos y cifras. Disponible en: https://idf.org/es/about-diabetes/diabetes-facts-figures/
4. Oficina Nacional de Estadística e Información. Anuario Estadístico de Cuba [Internet]. La Habana: ONEI; 2023 [citado 20 Nov 2023]. Disponible en: https://www.onei.gob.cu/sites/default/files/publicaciones/2023-08/19_salud_publica-_asistencia-social-2022-edicion-2023.pdf
5. Visseren FL, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J [Internet]. 2021 [citado 20 Nov 2023];42:3227-337. Disponible en: https://academic.oup.com/eurheartj/article/42/34/3227/6358713?login=true
6. Kengne AP, Patel A, Marre M, Travert F, Lievre M, Zoungas S, et al. Contemporary model for cardiovascular risk prediction in people with type 2 diabetes. Eur J Cardiovasc Prev Rehabil [Internet]. 2011 [citado 20 Nov 2023];18(3) 393-8. Disponible en: https://academic.oup.com/eurjpc/article/18/3/393/5931558?login=true
7. Medina Fuentes G, Carbajales León E, Carbajales León A. Características clínicas epidemiológicas de la diabetes mellitus en pacientes de un consultorio médico. REMIJ [Internet]. 2020 [citado 19 Nov 2023];21(2):[aprox. 12 p.]. Disponible en: https://remij.sld.cu/index.php/remij/article/view/291/501
8. Rafael Heredia A, Iglesias Osores S. Factores asociados a diabetes mellitus tipo 2 en pacientes atendidos en un hospital amazónico de Perú. UMP [Internet]. 2020 [citado 23 Nov 2023];16(2). Disponible en: https://revgaleno.sld.cu/index.php/ump/article/view/493/pdf
9. Huaynatti Tejedo DM. Características clínicas–epidemiológicas en pacientes con diabetes mellitus tipo 2 en hospital central de la policía Luis N. Sáenz en el año 2020. [tesis]. Lima-Perú: Universidad privada San Juan Bautista; 2022 [citado 20 Nov 2023]. Disponible en: https://repositorio.upsjb.edu.pe/bitstream/handle/20.500.14308/4070/T-TPMC-HUAYNATTI%20TEJEDO%20DIEGO%20MAURICIO.pdf?sequence=1&isAllowed=y
10. Gutiérrez Jiméne I, López Aparicio LR, Flores Díaz AG. Perfil clínico-epidemiológico de pacientes diabéticos con hipoglucemia que ingresan a urgencias. Revista electrónica semestral en Ciencias de la Salud [Internet]. 2022 [citado 20 Nov 2023];13(1):[aprox. 13 p.]. Disponible en: https://revistas.uaz.edu.mx/index.php/ibnsina/article/view/1106/1137
11. Rodríguez Salvá A, Céspedes Hernández L, Díaz Piñera A, García Roche R, Balcindes Acosta S. Brechas en el manejo del paciente diabético tipo 2 en un área metropolitana de La Habana. Rev Finlay [Internet]. 2019 [citado 30 May 2023];9(2):[aprox. 14 p.]. Disponible en: https://revfinlay.sld.cu/index.php/finlay/article/view/638/1754
12. Touyz RM, Rios FJ, Alves R, Neves KB, Camargo LL, Montezano AC. Oxidative Stress: A Unifying Paradigm in Hypertension. Can J Cardiol Finlay [Internet]. 2020 [citado 30 May 2023];36(5):659-70. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225748/
13. Patel A, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet [Internet]. 2007 [citado 30 May 2023];370(9590):829-40. Disponible en: https://pubmed.ncbi.nlm.nih.gov/17765963/
14. Buckley LF, Dixon DL, Wohlford GF, Wijesinghe DS, Baker WL, Van Tassell BW. Effect of intensive blood pressure control in patients with type 2 diabetes mellitus over 9 years of follow-up: A subgroup analysis of high-risk ACCORDION trial participants. Diabetes Obes Metab [Internet]. 2018 [citado 30 May 2023];20(6):1499-502. Disponible en: https://dom-pubs.pericles prod.literatumonline.com/doi/epdf/10.1111/dom.13248
15. Núñez Cortés JM, Botet JP. Dislipemia aterogénica: la otra pandemia, asociada a la diabesidad. Clin Investig Arterioscler [Internet]. 2021 [citado 30 May 2023];33(1):30-32. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833629/
16. Valle Pimienta T, Gato Armas CA, Rodríguez López M, Hernández Gómez JR, Rosales Álvarez G, Lago Díaz Y. Riesgo cardiovascular en pacientes ingresados en un Centro de Atención al diabético. Arch méd Camagüey [Internet]. 2023 [citado 23 Dic 2023];27:e9479. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-02552023000100036&lng=es
17. American Diabetes Association. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2021. Diabetes Care [Internet]. 2021 [citado 23 Dic 2023];44(suplem 1):125-50. Disponible en: https://diabetesjournals.org/care/article/44/Supplement_1/S125/30445/10-Cardiovascular-Disease-and-Risk-Management
18. Valdes Ramos E, Alvares Aleaga A. Índice predictivo de cardiopatía isquémica en personas con diabetes mellitus. Rev Cub Med Milit [Internet]. 2022 [citado 23 Oct 2023];51(4). Disponible en: https://revmedmilitar.sld.cu/index.php/mil/article/view/2190
19. Valente T, Arbex AK. Glycemic variability, oxidative stress, and impact on complications related to type 2 diabetes mellitus. Curr Diabetes Rev [Internet]. 2021 [citado 23 Oct 2023];17(7):1-11. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32674737/
20. Leal Ruiz E, Rodríguez Méndez L, Fusté M. Complicaciones crónicas en pacientes con diagnóstico reciente de diabetes mellitus tipo 2. Medicentro Electrónica [Internet]. 2019 [citado 23 Jun 2023];23(2):136-39. Disponible en: https://medicentro.sld.cu/index.php/medicentro/article/view/2758#:~:text=El%2080%20%25%20de%20los%20diagn%C3%B3sticos%20se%20realiz%C3%B3,enfermedades%20de%20la%20piel%20y%20esteatohepatitis%20no%20alcoh%C3%B3lica
21. Samaniego N. Características clínicas, epidemiológicas y complicaciones en pie diabético de pacientes con diabetes mellitus tipo 2 en el Hospital José Carrasco Arteaga, 2016-2018 [tesis]. Cuenca: Universidad Católica de Cuenca; 2020 [citado 20 Jun 2023]. Disponible en: https://dspace.ucacue.edu.ec/handle/ucacue/8517
22. Sánchez Delgado JA, Sánchez Lara NE. Epidemiología de la diabetes mellitus tipo 2 y sus complicaciones. Rev Finlay [Internet]. 2022 [citado 18 Dic 2023];12(2):[aprox. 8 p.]. Disponible en: https://revfinlay.sld.cu/index.php/finlay/article/view/1121/2114
23. Morales Carrasco AP, Rodríguez Conza D, Espinoza Diaz C, Vallejo Salazar J, Gaibor Ortiz A, Bravo Bohórquez G, et al. Características clínico-bioquímicas de pacientes diabéticos tipo2 del Instituto Ecuatoriano de Seguridad Social de Pastaza, Ecuador. Archivos Venezolanos de Farmacología y Terapéutica [Internet]. 2020 [citado 20 Nov 2023];39(4):251-55. Disponible en: https://www.revistaavft.com/images/revistas/2020/avft_4_2020/2_caracteristicas_psico_bioquimicas.pdf
24. Espinoza Murga G. Características clínicas y epidemiológicas de pacientes diabéticos tipo 2 del Servicio de Medicina del Hospital Eleazar Guzmán Barrón. Nuevo Chimbote, julio-diciembre 2019 [tesis]. Chimbote-Perú: Universidad Nacional Del Santa; 2020 [citado 23 Nov 2023]. Disponible en: https://repositorio.uns.edu.pe/bitstream/handle/20.500.14278/3534/85105.pdf?sequence=1&isAllowed=y
25. Arencibia Alvarez M de la C, Bell Castillo J, George Carrión W, Gallego Galano J,
George Bell MJ. Caracterización de los pacientes con diabetes mellitus tipo 2 atendidos en el Hospital General Docente Dr. Juan Bruno Zayas Alfonso. UMP [Internet]. 2020 [citado 20 Nov 2023];16(2). Disponible en: https://www.redalyc.org/journal/6382/638266622006/638266622006.pdf
26. Pomares Avalo AJ, Jorge González R, Alfonso Trujillo Y, Vázquez Núñez MA. Adherencia terapéutica y bienestar subjetivo en pacientes con diabetes mellitus tipo II. Finlay [Internet]. 2019 [citado 16 Jul 2023];9(3):[aprox. 4 p.]. Disponible en: http://revfinlay.sld.cu/index.php/finlay/article/view/672
27. Colom C, Rull A, Sanchez JL, Pérez A. Cardiovascular Disease in Type 1 Diabetes Mellitus: Epidemiology and Management of Cardiovascular Risk. J Clin Med [Internet]. 2021 [citado 16 Jul 2023];10(8):1798. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33924265/
28. Gedebjerg A, Almdal TP, Berencsi K, Rungby J, Nielsen JS, Witte DR, et al. Prevalence of micro- and macrovascular diabetes complications at time of type 2 diabetes diagnosis and associated clinical characteristics: A cross-sectional baseline study of 6958 patients in the Danish DD2 cohort. J Diabetes Complications [Internet]. 2018 [citado 16 Jul 2023];32(1):34-40. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29107454/
29. Martín Rioboó E, Brotons Cuixart C, Ruiz García A, Villafañe Sanz F, Frías Vargas M, Moyá Amengual A, et al. Luces y sombras de la Guía Europea ESC-2021 de Prevención de la Enfermedad Cardiovascular en la Práctica Clínica. Rev Esp Salud Pública [Internet]. 2023 [citado 20 Dic 2023];97. Disponible en:https://www.sanidad.gob.es/biblioPublic/publicaciones/recursos_propios/resp/revista_cdrom/VOL97/C_ESPECIALES/RS97C_202308064.pdf
30. Zamora Fung R, Blanc Márquez A, García Gázquez J, Borrego Moreno Y, Fundora Gonzales C. Estimación del riesgo cardiovascular en pacientes con diabetes mellitus tipo 2 en un consultorio médico. Univ Med Pinareña [Internet]. 2020 [citado 02 Ene 2023];16(1). Disponible en: https://www.medigraphic.com/pdfs/revunimedpin/ump-2020/ump201j.pdf

Published
How to Cite
Issue
Section
License
Copyright: Camagüey Medical Archive Magazine, offers immediately after being indexed in the SciELO Project; Open access to the full text of the articles under the principle of making available and free the research to promote the exchange of global knowledge and contribute to a greater extension, publication, evaluation and extensive use of the articles that can be used without purpose As long as reference is made to the primary source.
Conflicts of interest: authors must declare in a mandatory manner the presence or not of conflicts of interest in relation to the investigation presented.
(Download Statement of potential conflicts of interest)
The Revista Archivo Médico de Camagüey is under a License Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 International (CC BY 4.0).
This license allows others to distribute, to mix, to adjust and to build from its work, even for commercial purposes, as long as it is recognized the authorship of the original creation. This is the most helpful license offered. Recommended for maximum dissemination and use of licensed materials. The full license can be found at: https://creativecommons.org/licenses/